# Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

> **NCT00781547** · PHASE3 · COMPLETED · sponsor: **Göteborg University** · enrollment: 40 (actual)

## Conditions studied

- Abdominal Obesity
- Metabolic Syndrome
- Obesity

## Interventions

- **DRUG:** recombinant human growth hormone

## Key facts

- **NCT ID:** NCT00781547
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2003-09
- **Final completion:** 2005-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781547, "Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00781547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*